YTE reported $127.66M in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -113016000 68.36M
Agenus AGEN:US $ -35997000 20.08M
Agios Pharmaceuticals AGIO:US $ -101145000 3.68M
Alnylam Pharmaceuticals ALNY:US $ -146732000 47.83M
Amgen AMGN:US $ 2500M 196M
Biocryst Pharmaceuticals BCRX:US $ -49957000 2.22M
Biogen BIIB:US $ 531.5M 11.7M
Biomarin Pharmaceutical BMRN:US $ 29.33M 95.21M
Bluebird Bio BLUE:US $ -120346000 138.95M
Bristol Myers Squibb BMY:US $ 3188M 399M
Cerulean Pharma CERU:US $ -8400450 1.14M
Chemocentryx CCXI:US $ -38233000 1.82M
Clovis Oncology CLVS:US $ -50359000 2.35M
Cti Biopharma CTIC:US $ -35100000 275K
Eli Lilly And LLY:US $ 2569.9M 171.6M
Exelixis EXEL:US $ 83.24M 33.4M
Gilead Sciences GILD:US $ 2897M 1957M
Idera Pharmaceuticals IDRA:US $ -4182000 61K
Intercept Pharmaceuticals ICPT:US $ -10272000 10.59M
IONIS PHARMACEUT IONS:US $ -57504000 278.11M
Macrogenics MGNX:US $ -66638000 8.4M
Merk MRK:US $ 5059M 207M
Mirati Therapeutics MRTX:US $ -184218000 12.86M
Moderna Inc MRNA:US 4.23B 1.18B
Nektar Therapeutics NKTR:US $ -115085000 2.17M
Neurocrine Biosciences NBIX:US $ 3.1M 60.9M
Newlink Genetics NLNK:US -7731000 1.16M
Novartis NOVN:VX 3.15B 266M
Novartis NVS:US 3.15B 266M
Pfizer PFE:US $ 9995M 4136M
Ptc Therapeutics PTCT:US $ -86522000 1.79M
Puma Biotechnology PBYI:US $ -747000 7.58M
Regeneron Pharmaceuticals REGN:US $ 1286.6M 1353.1M
Sarepta Therapeutics SRPT:US $ -86881000 18.93M
Seattle Genetics SGEN:US $ -133050000 39.02M
Ultragenyx Pharmaceutical RARE:US $ -136632000 34.07M
Vertex Pharmaceuticals VRTX:US $ 1033.4M 157.68M
YTE INCY:US $ 127.66M 7.71M